Sign in
4

Changes in Ownership

GeneDx Holdings Corp. Filed Acc 0001944119-25-000012

CHIEF FINANCIAL OFFICER sold 6,609 shares at an average $108.38 ($716,261)

  • CHIEF FINANCIAL OFFICER acquired 1,246 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Feeley Kevin · CHIEF FINANCIAL OFFICER

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-30 Exercise or conversion : show line 1 in the form 10b5-1 +1,246 $32.67 $40,707 10,001 D
2025-09-30 Sale : show line 2 in the form 10b5-1 −344 $105.24 $36,203 9,657 D
2025-09-30 Sale : show line 3 in the form 10b5-1 −387 $106.86 $41,354 9,270 D
2025-09-30 Sale : show line 4 in the form 10b5-1 −2,715 $107.68 $292,361 6,555 D
2025-09-30 Sale : show line 5 in the form 10b5-1 −2,152 $108.67 $233,851 4,403 D
2025-09-30 Sale : show line 6 in the form 10b5-1 −421 $110.05 $46,330 3,982 D
2025-09-30 Sale : show line 7 in the form 10b5-1 −520 $111.93 $58,204 3,462 D
2025-09-30 Sale : show line 8 in the form 10b5-1 −70 $113.68 $7,958 3,392 D
Open-market sales · 6,609 sh · avg $108.38 · $716,261

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-09-30 Exercise or conversion : show line 9 in the form 10b5-1 Employee Stock Option (Right to Buy) −1,246 4,982 D
Loading xslF345X05/form4-10012025_081020.xml…